EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, synthesis, and anti-breast cancer activity evaluation of novel 3-cyanopyridine derivatives as PIM-1 inhibitors

Bahgat R M Hussein, Hayam H Mohammed, Eman A Ahmed, Omar Alshazly, Mamdouh F A Mohamed, Omran A Omran

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-11010-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Bahgat R M Hussein und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Sohag University, Sohag, 82524, Egypt. bahgat.ramadan@yahoo.com. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-pim-1, Antineoplastic Agents, Drug Design, Protein Kinase Inhibitors. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sohag University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel series of cyanopyridines 7a-j were synthesized via a one-pot multicomponent reaction of arylidene 4 with ammonium acetate 5 and respective methylaryl/heterylketones 6a-j in ethanol using vanillin as a natural starting material. Moreover, the regioselective alkylation reaction was studied by the treatment of cyanopyridines 7a-f and 7j with CH 3 I in the presence of K 2 CO 3 in DMF to afford O -methylcyanopyridines 8a-g (major) and N -methylcyanopyridines 9a-g (minor), whereas bipyridine 7h gave bipyridinium iodide salt 10 . All of the designed cyanopyridines were evaluated as anti-breast cancer (MCF-7) cell lines via PIM Kinase inhibitory activity, and the results displayed that some of them showed high activities, especially compounds 7h and 8f , which showed excellent activities against MCF-7 with IC 50 values of 1.89 and 1.69 μM, respectively, more potent than the reference drug doxorubicin. Mechanistically, compounds 7h and 8f exhibited strong in vitro PIM-1 kinase inhibitory activity with an IC 50 of 0.281 and 0.58 μM, respectively, compared to the reference staurosporine. Moreover, compound 7h arrested the tumor cells at the S phase and caused cell death mainly by inducing early and late apoptosis. Molecular docking studies against PIM-1 revealed good binding modes of the synthesized compound and showed agreement with the biological results. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-pim-1Antineoplastic AgentsDrug DesignProtein Kinase InhibitorsBreast NeoplasmsPyridinesHumansMCF-7 CellsMolecular Docking SimulationStructure-Activity RelationshipFemaleCell ProliferationApoptosisDrug Screening Assays, AntitumorMolecular Structure

Stichwörter der Autor:innen

AnticancerBreast cancerCyanopyridinesMolecular docking studiesPIM inhibitorsRegioselective

Substanzen

Proto-Oncogene Proteins c-pim-1Antineoplastic AgentsProtein Kinase InhibitorsPyridinesPIM1 protein, human

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Sohag University, Sohag, 82524, Egypt. bahgat.ramadan@yahoo.com.
  • Department of Chemistry, Faculty of Science, Sohag University, Sohag, 82524, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag, 82524, Egypt.

Förderung

  • Sohag University

Zitieren

APA

Hussein, B. R. M., Mohammed, H. H., Ahmed, E. A., Alshazly, O., Mohamed, M. F. A., & Omran, O. A. (2025). Design, synthesis, and anti-breast cancer activity evaluation of novel 3-cyanopyridine derivatives as PIM-1 inhibitors. Molecular Diversity. https://doi.org/10.1007/s11030-024-11010-8

Vancouver

Hussein BRM, Mohammed HH, Ahmed EA, Alshazly O, Mohamed MFA, Omran OA. Design, synthesis, and anti-breast cancer activity evaluation of novel 3-cyanopyridine derivatives as PIM-1 inhibitors. Molecular Diversity. 2025. doi:10.1007/s11030-024-11010-8

BibTeX
@article{Hussein2025,
  author = {Hussein, Bahgat R M and Mohammed, Hayam H and Ahmed, Eman A and Alshazly, Omar and Mohamed, Mamdouh F A and Omran, Omran A},
  title = {Design, synthesis, and anti-breast cancer activity evaluation of novel 3-cyanopyridine derivatives as PIM-1 inhibitors},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-11010-8}
}
Kostenlos starten →